Does Total Arterial Revascularisation Confer a Survival Advantage in Moderate Left Ventricular Dysfunction? A Retrospective Cohort Study of 1866 Patients
Journal of Cardiovascular Development and Disease · 19.06.2026 · 13 (6) · 278
DOI: 10.3390/jcdd13060278 ↗Kurz gefasst
Kohortenstudie in der Zeitschrift Journal of Cardiovascular Development and Disease, online erschienen am 19.06.2026. Verfasst von Albaraa Al-Holy und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiac Surgery, Harefield Hospital, London UB9 6JH, UK. Die Arbeit nennt 14 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Objectives
The optimal conduit strategy for coronary artery bypass grafting (CABG) in patients with moderate left ventricular dysfunction (LVEF 30–49%) remains debated. While total arterial grafting (TAG) has shown benefits in broader populations, its role in this higher-risk subgroup is unclear. This study aimed to compare short-term outcomes and long-term survival between single arterial grafting (SAG) and TAG in patients with moderate LV dysfunction undergoing CABG.
Methods
A retrospective analysis of 1866 patients was performed, with 640 patients matched using propensity scores (320 SAG vs. 320 TAG). Preoperative, intraoperative, and postoperative variables were assessed. Survival was evaluated using Kaplan–Meier analysis and Cox regression.
Results
Matched cohorts were well balanced across baseline characteristics. Long-term survival at 10 and 15 years was numerically higher in the TAG group (85.8% and 79.7%) compared to SAG (81.7% and 74.2%), though not statistically significant (log-rank p = 0.862). Multivariate Cox regression identified age (HR 1.045, p < 0.001), NYHA class (NYHA III HR 0.610, p = 0.003), previous cardiac surgery (HR 0.501, p = 0.006), and off-pump CABG (HR 1.521, p < 0.001) as independent predictors of mortality. Grafting strategy (TAG vs. SAG) was not independently associated with long-term mortality (HR 1.005, p = 0.966).
Conclusion
TAG is safe and feasible in patients with moderate LV dysfunction undergoing isolated CABG, with comparable short-term outcomes. Although unadjusted analyses suggested improved long-term survival, this difference was not observed after propensity matching or multivariable adjustment, and grafting strategy was not independently associated with mortality.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Cardiac Surgery, Harefield Hospital, London UB9 6JH, UK.
- Department of Anaesthesia and Intensive Care, Harefield Hospital, London UB9 6JH, UK.
ORCID-Profile: Shahzad G Raja
Zitieren
APA
Al-Holy, A., Marczin, N., Bhudia, S. K., Raja, S. G., & Cardiac Outcomes Research Group and Initiative (CORGI) (2026). Does Total Arterial Revascularisation Confer a Survival Advantage in Moderate Left Ventricular Dysfunction? A Retrospective Cohort Study of 1866 Patients. Journal of Cardiovascular Development and Disease, 13(6), 278. https://doi.org/10.3390/jcdd13060278
Vancouver
Al-Holy A, Marczin N, Bhudia SK, Raja SG, Cardiac Outcomes Research Group and Initiative (CORGI). Does Total Arterial Revascularisation Confer a Survival Advantage in Moderate Left Ventricular Dysfunction? A Retrospective Cohort Study of 1866 Patients. Journal of Cardiovascular Development and Disease. 2026;13(6):278. doi:10.3390/jcdd13060278
BibTeX
@article{AlHoly2026,
author = {Al-Holy, Albaraa and Marczin, Nandor and Bhudia, Sunil K and Raja, Shahzad G and Cardiac Outcomes Research Group and Initiative (CORGI), Cardiac Outcomes Research Group and Initiative (CORGI)},
title = {Does Total Arterial Revascularisation Confer a Survival Advantage in Moderate Left Ventricular Dysfunction? A Retrospective Cohort Study of 1866 Patients},
journal = {Journal of Cardiovascular Development and Disease},
year = {2026},
volume = {13},
number = {6},
pages = {278},
doi = {10.3390/jcdd13060278}
}
EUVIMED